Rehan Qayyum

Summary

Publications

  1. ncbi request reprint Cardiovascular effects of the thiazolidinediones
    Rehan Qayyum
    Calhoun Cardiology Center University of Connecticut Health Center, Farmington, CT 06030 2202, USA
    Diabetes Metab Res Rev 22:88-97. 2006
  2. ncbi request reprint A meta-analysis of the effect of thiazolidinediones on blood pressure
    Rehan Qayyum
    Prudich Medical Center, Montcalm, WV 24737, USA
    J Clin Hypertens (Greenwich) 8:19-28. 2006
  3. ncbi request reprint Meta-analysis of the effect of thiazolidinediones on serum C-reactive protein levels
    Rehan Qayyum
    Prudich Medical Center, Montcalm, West Virginia
    Am J Cardiol 97:655-8. 2006
  4. ncbi request reprint Achievement of national cholesterol education program goals by patients with dyslipidemia in rural ambulatory care settings
    Rehan Qayyum
    Jim and Pat Calhoun Cardiology Center, University of Connecticut Health Center, Farmington, CT, USA
    Prev Cardiol 9:192-7. 2006
  5. ncbi request reprint Systematic review: comparative effectiveness and safety of premixed insulin analogues in type 2 diabetes
    Rehan Qayyum
    Evidence Based Practice Center, Johns Hopkins University, Baltimore, Maryland, USA
    Ann Intern Med 149:549-59. 2008

Detail Information

Publications5

  1. ncbi request reprint Cardiovascular effects of the thiazolidinediones
    Rehan Qayyum
    Calhoun Cardiology Center University of Connecticut Health Center, Farmington, CT 06030 2202, USA
    Diabetes Metab Res Rev 22:88-97. 2006
    ..Thus, by modulating gene expression, thiazolidinediones may provide a novel method for the prevention and treatment of cardiovascular diseases...
  2. ncbi request reprint A meta-analysis of the effect of thiazolidinediones on blood pressure
    Rehan Qayyum
    Prudich Medical Center, Montcalm, WV 24737, USA
    J Clin Hypertens (Greenwich) 8:19-28. 2006
    ..91 to -2.02) and diastolic BP by 1.84 mm Hg (95% confidence interval, -3.43 to -0.25). Thus, TZDs lower both systolic and diastolic BP, albeit the BP-lowering effect is small and may not be of clinical significance...
  3. ncbi request reprint Meta-analysis of the effect of thiazolidinediones on serum C-reactive protein levels
    Rehan Qayyum
    Prudich Medical Center, Montcalm, West Virginia
    Am J Cardiol 97:655-8. 2006
    ..24 mg/L, 95% confidence interval -2.15 to -0.32 mg/L, p = 0.008) compared with nondiabetic patients (mean -0.27 mg/L, 95% confidence interval -0.41 to -0.14 mg/L, p <0.0001)...
  4. ncbi request reprint Achievement of national cholesterol education program goals by patients with dyslipidemia in rural ambulatory care settings
    Rehan Qayyum
    Jim and Pat Calhoun Cardiology Center, University of Connecticut Health Center, Farmington, CT, USA
    Prev Cardiol 9:192-7. 2006
    ..13-4.89). These results indicate that a significant proportion of patients with dyslipidemia in rural practices do not achieve management goals. Strategies to improve lipid management in rural practices are needed...
  5. ncbi request reprint Systematic review: comparative effectiveness and safety of premixed insulin analogues in type 2 diabetes
    Rehan Qayyum
    Evidence Based Practice Center, Johns Hopkins University, Baltimore, Maryland, USA
    Ann Intern Med 149:549-59. 2008
    ..Evidence comparing premixed insulin analogues (a mixture of rapid-acting and intermediate-acting insulin analogues) with other antidiabetic agents is urgently required to guide appropriate therapy...